Correlation Between Aileron Therapeutics and Vaccinex

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aileron Therapeutics and Vaccinex at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aileron Therapeutics and Vaccinex into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aileron Therapeutics and Vaccinex, you can compare the effects of market volatilities on Aileron Therapeutics and Vaccinex and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aileron Therapeutics with a short position of Vaccinex. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aileron Therapeutics and Vaccinex.

Diversification Opportunities for Aileron Therapeutics and Vaccinex

-0.63
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Aileron and Vaccinex is -0.63. Overlapping area represents the amount of risk that can be diversified away by holding Aileron Therapeutics and Vaccinex in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaccinex and Aileron Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aileron Therapeutics are associated (or correlated) with Vaccinex. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaccinex has no effect on the direction of Aileron Therapeutics i.e., Aileron Therapeutics and Vaccinex go up and down completely randomly.

Pair Corralation between Aileron Therapeutics and Vaccinex

Given the investment horizon of 90 days Aileron Therapeutics is expected to under-perform the Vaccinex. But the stock apears to be less risky and, when comparing its historical volatility, Aileron Therapeutics is 1.86 times less risky than Vaccinex. The stock trades about -0.39 of its potential returns per unit of risk. The Vaccinex is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  374.00  in Vaccinex on August 29, 2024 and sell it today you would lose (5.00) from holding Vaccinex or give up 1.34% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Aileron Therapeutics  vs.  Vaccinex

 Performance 
       Timeline  
Aileron Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Aileron Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile basic indicators, Aileron Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.
Vaccinex 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vaccinex has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Aileron Therapeutics and Vaccinex Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aileron Therapeutics and Vaccinex

The main advantage of trading using opposite Aileron Therapeutics and Vaccinex positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aileron Therapeutics position performs unexpectedly, Vaccinex can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaccinex will offset losses from the drop in Vaccinex's long position.
The idea behind Aileron Therapeutics and Vaccinex pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings